These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 548916)

  • 1. [Hypopituitarism and hyperlipidemia. Protective effect of growth hormone deficiency against atherosclerosis (author's transl)].
    de Gennes JL; Turpin G; Heshmati HM; Lebrun A
    Nouv Presse Med; 1979 Dec; 8(47):3877-80. PubMed ID: 548916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypopituitarism and hyperlipidemia. Protective effect of growth hormone deficiency against atherosclerosis (author's transl)].
    de Gennes JL; Turpin G; Heshmati HM; Lebrun A
    Ann Endocrinol (Paris); 1979; 40(6):557-8. PubMed ID: 547877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of hypopituitarism in a tertiary care hospital of eastern India--is quality of life different in patients with growth hormone deficiency?
    Chatterjee P; Mukhopadhyay P; Pandit K; Roychowdhury B; Sarkar D; Mukherjee S; Chowdhury S
    J Indian Med Assoc; 2008 Jun; 106(6):384-5, 388. PubMed ID: 18839650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
    Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sheehan's syndrome as a rare cause of anaemia secondary to hypopituitarism.
    Gokalp D; Tuzcu A; Bahceci M; Arikan S; Bahceci S; Pasa S
    Ann Hematol; 2009 May; 88(5):405-10. PubMed ID: 18797868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic features of 20 patients with Sheehan's syndrome.
    Dökmetaş HS; Kilicli F; Korkmaz S; Yonem O
    Gynecol Endocrinol; 2006 May; 22(5):279-83. PubMed ID: 16785150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of severe growth hormone deficiency on the skin of patients with Sheehan's syndrome.
    Borlu M; Tanriverdi F; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):199-204. PubMed ID: 17243955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
    Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypopituitarism presenting as a mixed hyperlipidaemia.
    Kilpatrick ES; Patmore JE; Rowland-Hill C; Atkin SL
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):344-5. PubMed ID: 15298750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tooth and face abnormalities associated with pituitary growth hormone insufficiency].
    Liapi C; Ginisty D; Chaussain JL; Job JC
    Arch Fr Pediatr; 1985 Dec; 42(10):829-33. PubMed ID: 3833098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency.
    Takahashi Y; Iida K; Takahashi K; Yoshioka S; Fukuoka H; Takeno R; Imanaka M; Nishizawa H; Takahashi M; Seo Y; Hayashi Y; Kondo T; Okimura Y; Kaji H; Kitazawa R; Kitazawa S; Chihara K
    Gastroenterology; 2007 Mar; 132(3):938-43. PubMed ID: 17324404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial combined hyperlipoproteinemia. Evidence for a role of growth hormone deficiency in effecting its manifestation.
    Merimee TJ
    J Clin Invest; 1980 Apr; 65(4):829-35. PubMed ID: 6987267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can normalization of vascular cytoadhesive activity be explained by the anti-atherosclerosis effect of growth hormone?].
    Marek J; Kvasnicka J; Weiss V; Marková M; Hass T
    Cas Lek Cesk; 1998 Nov; 137(22):690-3. PubMed ID: 9929936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.